Bioactive Compound Screening in Natural Product Extracts

Bioactive compound screening in natural product extracts has become a cornerstone of early-stage drug discovery, harnessing the chemical diversity of plants, fungi and marine organisms. This discipline integrates advanced separation methods, bioassays and computational tools to identify molecules with therapeutic potential. Extracts are typically fractionated by chromatography and subjected to activity-guided assays targeting enzymes, receptors or cellular pathways. Parallel developments in mass spectrometry have enabled the rapid characterisation of active components even within highly complex mixtures. Recent advances emphasise combining orthogonal techniques—such as affinity-based capture and in silico modelling—to reveal both single active constituents and synergistic multicomponent interactions. This holistic strategy not only accelerates the identification of lead compounds for metabolic, inflammatory or oncological indications but also provides insight into traditional herbal formulations. The global significance of such screening extends from the discovery of novel drug leads to the validation of ethnomedicinal practices and the sustainable development of natural resources.

Research from Nature Portfolio

A pioneering strategy has been introduced that reconceptualises screening libraries derived from herbal extracts. Instead of relying solely on crude mixtures, this approach reconstructs simplified libraries organised by chemical families, thereby reducing complexity and enhancing the detection of low-abundance actives. Using a prototypical enzyme model, researchers demonstrated the concurrent identification of minor lead compounds, synergistic combinations and multicomponent interactions that would have been overlooked by conventional single-compound screens. This methodology underscores the importance of integrating chemical-family fractionation with bioactivity assays and highlights a shift towards more nuanced, systems-level investigations of natural extracts.

Bioactive Compound Screening in Natural Product Extracts publication trend

The graph below shows the total number of articles in bioactive compound screening in natural product extracts across all publications each year (not limited to Nature Index journals).

Technical terms

Affinity ultrafiltration: A technique using membrane filters to separate protein-bound ligands from unbound small molecules in complex mixtures.

High-performance liquid chromatography (HPLC): A separation method that resolves constituents of an extract based on their interaction with stationary and mobile phases under high pressure.

Mass spectrometry (MS): An analytical tool that measures mass-to-charge ratios of ionised compounds, enabling structural identification and quantification.

Molecular docking: A computational procedure that predicts the preferred orientation and binding energy of a small molecule within a target protein’s active site.

High-throughput screening (HTS): An automated process that rapidly evaluates large numbers of samples or fractions for biological activity against specific targets.

References

1. A chemical family-based strategy for uncovering hidden bioactive molecules and multicomponent interactions in herbal medicines. Scientific Reports (2016).
2. Rapid Screening for α-Glucosidase Inhibitors from Gymnema sylvestre by Affinity Ultrafiltration–HPLC-MS. Frontiers in Pharmacology (2017).
3. Rapid Investigation and Screening of Bioactive Components in Simo Decoction via LC-Q-TOF-MS and UF-HPLC-MD Methods. Molecules (2018).
4. Potential Antioxidant and Anti-Inflammatory Effects of Lonicera japonica and Citri Reticulatae Pericarpium Polyphenolic Extract (LCPE). Antioxidants (2023).